Vaxcyte Research Development from 2010 to 2026

PCVX Stock  USD 46.59  1.45  3.02%   
Vaxcyte Research Development yearly trend continues to be fairly stable with very little volatility. Research Development is likely to outpace its year average in 2026. During the period from 2010 to 2026, Vaxcyte Research Development regression line of annual values had r-squared of  0.68 and arithmetic mean of  143,066,543. View All Fundamentals
 
Research Development  
First Reported
2019-03-31
Previous Quarter
194.2 M
Current Value
209.9 M
Quarterly Volatility
59.1 M
 
Covid
Check Vaxcyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers, such as Interest Income of 132.8 M, Depreciation And Amortization of 19.1 M or Interest Expense of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.82. Vaxcyte financial statements analysis is a perfect complement when working with Vaxcyte Valuation or Volatility modules.
  
Build AI portfolio with Vaxcyte Stock
Check out the analysis of Vaxcyte Correlation against competitors.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

Latest Vaxcyte's Research Development Growth Pattern

Below is the plot of the Research Development of Vaxcyte over the last few years. It is Vaxcyte's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxcyte's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Vaxcyte Research Development Regression Statistics

Arithmetic Mean143,066,543
Geometric Mean48,651,859
Coefficient Of Variation142.60
Mean Deviation163,151,943
Median30,145,000
Standard Deviation204,016,939
Sample Variance41622.9T
Range562.8M
R-Value0.83
Mean Square Error14138T
R-Squared0.68
Significance0.000045
Slope33,354,035
Total Sum of Squares665966.6T

Vaxcyte Research Development History

2026575.5 M
2025548.1 M
2024476.6 M
2023332.3 M
2022169.5 M
202178.4 M
202073.6 M

About Vaxcyte Financial Statements

Vaxcyte investors use historical fundamental indicators, such as Vaxcyte's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaxcyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development548.1 M575.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.